John Koreth, MBBS, DPhil

    John Koreth, MBBS, DPhil

    Associate Professor of Medicine, Harvard Medical School
    Senior Physician, Dana-Farber Cancer Institute

    Drawing First Blood

    • Should Patients With Myelodysplastic Syndromes Undergo Transplant? Monday, May 1st, 2017

      John Koreth, MBBS, DPhilAssociate Professor of Medicine, Harvard Medical School Senior Physician, Dana-Farber Cancer InstituteBart Scott, MDAssistant Professor of Medicine, Division of Oncology, University of Washington Director of Hematology and Hematologic Malignancies, Seattle Cancer Care Alliance For patients with myelodysplastic syndromes (MDS), hematopoietic cell transplantation (HCT) is the only potentially curative option, but the rates [...]

    back to top
    SHARE